NCT06526819
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06526819
Title A Phase 1/2 Study of SMP-3124LP in Adults With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sumitomo Pharma America, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Sarah Cannon Research Institute at HealthOne RECRUITING Denver Colorado 80218 United States Details
Ohio State University RECRUITING Columbus Ohio 43210 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
Vanderbilt-Ingram Cancer Center RECRUITING Nashville Tennessee 37232 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
National Cancer Center Hospital East RECRUITING Kashiwa-shi 277-8577 Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field